BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Non Operating Income (2022)

Updated

BioXcel Therapeutics (BTAIQ) reported Non Operating Income of $62,000 for Q3 2022.

Analysis

BioXcel Therapeutics (BTAIQ) Non Operating Income (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 269.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -73.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 387.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 62,000.00
API Access

BioXcel Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY